Chemoinformaics analysis of 2beta,3alpha-Dihydrotabersonine
| Molecular Weight | 338.451 | nRot | 2 |
| Heavy Atom Molecular Weight | 312.243 | nRig | 1 |
| Exact Molecular Weight | 338.199 | nRing | 5 |
| Solubility: LogS | -6.832 | nHRing | 3 |
| Solubility: LogP | 10.369 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 56.2106 |
| nHD | 1 | BPOL | 30.9674 |
| QED | 0.179 |
| Synth | 1.671 |
| Natural Product Likeliness | 0.257 |
| NR-PPAR-gamma | 0.963 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.006 |
| CACO-2 | -5.221 |
| MDCK | 0.00000897 |
| BBB | 0.006 |
| PPB | 0.988577 |
| VDSS | 1.717 |
| FU | 0.0065071 |
| CYP1A2-inh | 0.088 |
| CYP1A2-sub | 0.15 |
| CYP2c19-inh | 0.198 |
| CYP2c19-sub | 0.052 |
| CYP2c9-inh | 0.043 |
| CYP2c9-sub | 0.996 |
| CYP2d6-inh | 0.033 |
| CYP2d6-sub | 0.024 |
| CYP3a4-inh | 0.073 |
| CYP3a4-sub | 0.006 |
| CL | 2.802 |
| T12 | 0.182 |
| hERG | 0.235 |
| Ames | 0.005 |
| ROA | 0.011 |
| SkinSen | 0.959 |
| Carcinogencity | 0.028 |
| EI | 0.919 |
| Respiratory | 0.818 |
| NR-Aromatase | 0.111 |
| Antiviral | No |
| Prediction | 0.739493 |